United Therapeutics (NASDAQ:UTHR) Director Sells $495,950.00 in Stock
2 Articles
2 Articles
United Therapeutics (NASDAQ:UTHR) Director Sells $495,950.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Patusky sold 1,000 shares of the firm's stock in a transaction on Monday, December 15th. The shares were sold at an average price of $495.95, for a total transaction of $495,950.00. Following the sale, the director owned 1,490 shares in the company, valued at approximately $738,965.50. This trade represents a 40.16% decrease in their position. The transaction wa…
United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 3,517 Shares
United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 3,517 shares of United Therapeutics stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $495.36, for a total transaction of $1,742,181.12. Following the completion of the transaction, the chief financial officer directly owned 8,142 shares […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
